Josh Lehrer, CEO of Graphite Bio, discusses his company’s experimental sickle cell gene editing therapy, how it works, and what makes it a next-generation gene editor.  @globalgenes #RARECast

Josh Lehrer, CEO of Graphite Bio, discusses his company’s experimental sickle cell gene editing therapy, how it works, and what makes it a next-generation gene editor. @globalgenes #RARECast

A Find-and-Replace Approach to Fixing the Mutation Underlying Sickle Cell Disease

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share A Find-and-Replace Approach to Fixing the Mutation Underlying Sickle Cell Disease

Sign up to save your podcasts

A Find-and-Replace Approach to Fixing the Mutation Underlying Sickle Cell Disease

A Find-and-Replace Approach to Fixing the Mutation Underlying Sickle Cell Disease